NEW YORK (June 14, 2023)— Dr. Jonathan Weinsaft, an esteemed physician-scientist who focuses on clinical research and cardiovascular imaging, has been appointed chief of the Greenberg Division of Cardiology at Weill Cornell Medicine and NewYork-Presbyterian/Weill Cornell Medical Center, effective July 1.
Credit: Weill Cornell Medicine
NEW YORK (June 14, 2023)— Dr. Jonathan Weinsaft, an esteemed physician-scientist who focuses on clinical research and cardiovascular imaging, has been appointed chief of the Greenberg Division of Cardiology at Weill Cornell Medicine and NewYork-Presbyterian/Weill Cornell Medical Center, effective July 1.
The Greenberg Division of Cardiology, housed within the Weill Department of Medicine, is dedicated to diagnosing and treating patients with disorders of the heart and blood vessels that comprise the cardiovascular system.
In his new role, Dr. Weinsaft will further strengthen the division as a leader in scientific and technological innovation in cardiology, growing its research programs and translating these findings into exceptional patient care. He will also prioritize the training and mentoring of the next generation of junior faculty and fellows specializing in cardiovascular conditions and work to strengthen cardiovascular collaborations across NewYork-Presbyterian campuses affiliated with Weill Cornell Medicine.
“Dr. Weinsaft is an outstanding physician-scientist, a leader in his field and a dedicated mentor,” said Dr. John Leonard, interim chair of the Weill Department of Medicine and interim physician-in-chief at NewYork-Presbyterian/Weill Cornell Medical Center. “He is an ideal choice for guiding the Greenberg Division of Cardiology’s next chapter. I look forward to working with him as we continue to advance our efforts in research and patient care through collaboration with our experts in cardiology and related disciplines across our academic medical center.”
Dr. Weinsaft, who joined Weill Cornell Medicine and NewYork-Presbyterian/Weill Cornell Medical Center in 2005, is currently the Antonio M. Gotto Jr., M.D. Professor in Atherosclerosis and Lipid Research and a professor of medicine and of medicine in radiology. He also serves as director of the non-invasive cardiac imaging program at Weill Cornell Medicine and NewYork-Presbyterian/Weill Cornell Medical Center.
Dr. Weinsaft succeeds Dr. Bruce Lerman, who has led the division since 1995 and will remain on Weill Cornell Medicine’s faculty. Dr. Lerman will lead the Greenberg Institute for Cardiac Electrophysiology, where he will continue his clinical care and research activities.
Dr. Weinsaft is an expert in an array of cardiac imaging modalities, including technical development and clinical applications. He has held leadership positions in multiple cardiology programs over the last two decades, including cardiac MRI and nuclear cardiology programs that span Weill Cornell Medicine and NewYork-Presbyterian/Weill Cornell Medical Center, other Weill Cornell Medicine-affiliated NewYork-Presbyterian campuses, and Memorial Sloan Kettering Cancer Center.
“I’m excited and humbled to take on this unique opportunity to lead our world-class cardiology division, especially as Weill Cornell Medicine and NewYork-Presbyterian have been central to my career since the beginning,” Dr. Weinsaft said. “Working with our faculty, trainees and staff who are all focused on excellence is an honor and a privilege.”
As division chief, Dr. Weinsaft will collaborate with colleagues in related divisions and departments, recognizing that patients with cardiovascular diseases are treated by multidisciplinary experts in cardiology and cardiac surgery. “By fostering teamwork and collaboration between cardiovascular disciplines and among our affiliated campuses, I look forward to leading the continued growth of our clinical, research and educational programs, which are intrinsically linked and focused on improving patients’ outcomes,” he said.
About Dr. Jonathan Weinsaft
Dr. Weinsaft is a physician-scientist with over a decade-long track record of continuous extramural research support as provided by the National Institutes of Health and other agencies. He has served as principal or co-principal investigator for funded studies investigating new methods to measure blood oxygen saturation in patients with heart failure; diseases of the heart valves and how the valves respond to therapies; and understanding how the major heart artery, the aorta, responds to surgical graft replacement. He is also developing an NIH-funded training program to provide mentorship and training in basic and translational clinical cardiovascular research to trainees at Weill Cornell Medicine, Memorial Sloan Kettering Cancer Center and The Rockefeller University.
Dr. Weinsaft has authored more than 140 articles and mentored more than 100 trainees who have authored manuscripts published in leading, peer-reviewed journals. He has served in editorial positions for journals including Circulation: Cardiovascular Imaging and the Journal of the American College of Cardiology: Cardiovascular Imaging. In addition, Dr. Weinsaft has served on NIH study sections and expert consensus panels for many cardiovascular conditions. He is a member of the American Heart Association, the American College of Cardiology, the Society for Cardiac Magnetic Resonance and the National Marfan Foundation Scientific Advisory Board. An expert in his field, Dr. Weinsaft is a frequently invited speaker at leading medical institutions nationally and internationally.
Dr. Weinsaft received his bachelor’s, master’s and medical degrees from New York University. He completed an internal medicine residency and a cardiology fellowship at NewYork-Presbyterian/Weill Cornell Medical Center, followed by a fellowship in cardiac imaging at Duke University Medical Center. He then returned to Weill Cornell Medicine and NewYork-Presbyterian/Weill Cornell Medical Center, where he has served on faculty since 2005. Dr. Weinsaft holds adjunct clinical and faculty appointments at NewYork-Presbyterian Queens and Memorial Sloan Kettering Cancer Center, respectively, in conjunction with integrated program development initiatives.
Weill Cornell Medicine
Weill Cornell Medicine is committed to excellence in patient care, scientific discovery and the education of future physicians in New York City and around the world. The doctors and scientists of Weill Cornell Medicine — faculty from Weill Cornell Medical College, Weill Cornell Graduate School of Medical Sciences, and Weill Cornell Physician Organization — are engaged in world-class clinical care and cutting-edge research that connect patients to the latest treatment innovations and prevention strategies. Located in the heart of the Upper East Side’s scientific corridor, Weill Cornell Medicine’s powerful network of collaborators extends to its parent university Cornell University; to Qatar, where Weill Cornell Medicine-Qatar offers a Cornell University medical degree; and to programs in Tanzania, Haiti, Brazil, Austria and Turkey. Weill Cornell Medicine faculty provide exemplary patient care at NewYork-Presbyterian/Weill Cornell Medical Center, NewYork-Presbyterian Westchester Behavioral Health Center, NewYork-Presbyterian Lower Manhattan Hospital, NewYork-Presbyterian Queens and NewYork-Presbyterian Brooklyn Methodist Hospital. Weill Cornell Medicine is also affiliated with Houston Methodist. For more information, visit weill.cornell.edu.
NewYork-Presbyterian
NewYork-Presbyterian is one of the nation’s most comprehensive, integrated academic healthcare systems, encompassing 10 hospitals across the Greater New York area, nearly 200 primary and specialty care clinics and medical groups, and an array of telemedicine services.
A leader in medical education, NewYork-Presbyterian Hospital is the only academic medical center in the nation affiliated with two world-class medical schools, Weill Cornell Medicine and Columbia University Vagelos College of Physicians and Surgeons. This collaboration means patients have access to the country’s leading physicians, the full range of medical specialties, latest innovations in care, and research that is developing cures and saving lives.
Founded 250 years ago, NewYork-Presbyterian Hospital has a long legacy of medical breakthroughs and innovation, from the invention of the Pap test to pioneering the groundbreaking heart valve replacement procedure called TAVR.
NewYork-Presbyterian’s 48,000 employees and affiliated physicians are dedicated to providing the highest quality, most compassionate care to New Yorkers and patients from across the country and around the world.
For more information, visit www.nyp.org and find us on Facebook, Twitter, Instagram, and YouTube.
